TNF and histiocytic sarcoma: Systemic administration of anti-TNF-α biologics can be responsible for unexpected paradoxical psoriasiform reactions in patients treated for immune-mediated inflammatory conditions, such as HS, rheumatoid arthritis, and inflammatory bowel disease (15, 16).